Overview


According to FutureWise analysis the market for Interventional Oncology in 2023 is US$ 2.03 billion, and is expected to reach US$ 3.5 billion by 2031 at a CAGR of 7.02%.

Interventional oncology deals with image guidance carrying minimally invasive medical procedures for diagnosis, palliation and treatment of various cancer types. Various image-guiding techniques like fluoroscopy, ultrasound and computed tomography are implemented in interventional oncology procedures to treat and diagnose a particular site that is affected with cancer or pain. This procedure is often performed with other cancer treatments like chemotherapy, radiation therapy and surgery. Interventional oncological procedures offer multiple advantages like shorter hospital stays, quick recovery, more precise treatment and minimal side effects.

Technological advancements in interventional oncology, advantages of minimally invasive surgical procedures and increase in the funds offered by the government are some factors that have assisted in the proliferation of the market.Product-wise, the market is fragmented into embolization devices, non-radioactive embolic agents, ablation devices, support devices and guidewires. The ablation devices segment is further segmented into radiofrequency ablation devices, microwave ablation devices, cryoablation devices. The embolization devices segment is anticipated to register a remarkable CAGR during the forecast period. The process of embolization has multiple benefits which is why it is primarily preferred worldwide. It is the process of embolus lodging inside the bloodstream to block the blood supply to the tumour. The blood vessels are selectively occluded by introducing emboli using irradiation or chemical techniques.

Another widely used interventional oncology technique is radiotherapy which is used for treating rare diseases like thyroid, to restrict non-cancerous cell growth and blood disorders. Radiotherapy is the process that involves radiation through heat or light energy. This segment has immense potential and it is expected to showcase significant market growth during the forecast period.

Based on the type of cancer, the market is bifurcated into renal cancer, lung cancer, kidney cancer, bone cancer, hepatocellular carcinoma, osteosarcoma and other cancers. The liver cancer segment is anticipated to witness remarkable market growth during the forecast period owing to the technological advancements in ablation and embolization devices.The market is regionally fragmented into North America, Europe, Asia Pacific, Latin America and Middle East, Africa. The European and North American regions are expected to showcase significant market growth over the forecast period owing to an increasing cancer patient population. Furthermore, well-established health care infrastructure, effective cancer management, increasing adoption of minimally invasive surgical procedures are some of the key factors responsible for the proliferation of the market.

  • Medtronic
  • Boston Scientific
  • BTG Plc.
  • Terumo
  • Merit Medical
  • Sirtex
  • Ethicon
  • Cook Medical
  • Teleflex
  • HealthTronics
  • MedWaves Medical
  • IceCure Medical
  • Interface Biomaterial BV
  • Mermaid Medicals
  • ABK Biomedical
  • Guerbet
  • Endo Shape
  • Instylla
  • Shape Memory Medical
  • Monteris Medical
  • Trisalus Lifesciences

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Embolization Devices
    • Radioembolic Agents
    • Non-Radioactive Embolic Agents
  • Ablation Devices
    • Radiofrequency Ablation Devices
    • Microwave Ablation Devices
    • Cryoablation Devices
    • Other Ablation Devices
  • Support Devices
    • Microcatheters
    • Guidewires

By Procedure

  • Thermal Tumour Ablation
  • Non-thermal Tumour Ablation
  • Transcatheter Arterial Chemoembolization
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
  • Transcatheter Arterial Embolization/Bland Embolization

By Cancer Type

  • Liver Cancer
  • Lung Cancer
  • Bone Cancer
  • Kidney Cancer
  • Other Cancers

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects for market
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the market by product, by procedure, by cancer type and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East
  • Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Interventional Oncology Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Interventional Oncology Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Interventional Oncology Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Interventional Oncology Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Interventional Oncology Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Embolization Devices
         1.1. Radioembolic Agents
         1.2. Non-Radioactive Embolic Agents
        2. Ablation Devices
         2.1. Radiofrequency Ablation Devices
         2.2. Microwave Ablation Devices
         2.3. Cryoablation Devices
         2.4. Other Ablation Devices
        3. Support Devices
         3.1. Microcatheters
         3.2. Guidewires

  • 8.   Interventional Oncology Market, By Procedure Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Thermal Tumour Ablation
        2. Non-thermal Tumour Ablation
        3. Transcatheter Arterial Chemoembolization
        4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
        5. Transcatheter Arterial Embolization/Bland Embolization

  • 9.   Interventional Oncology Market, By Cancer Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Liver Cancer
        2. Lung Cancer
        3. Bone Cancer
        4. Kidney Cancer
        5. Other Cancers

  • 10.   North America Interventional Oncology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Interventional Oncology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Venezuela
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Interventional Oncology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9. Rest of Western Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Interventional Oncology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Taiwan
         2.9. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Interventional Oncology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    •   1. Medtronic
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Boston Scientific
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. BTG Plc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Terumo
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5 . Merit Medical
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6 . Sirtex
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Ethicon
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Cook Medical
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Teleflex
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. HealthTronics
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. MedWaves Medical
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. IceCure Medical
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Interface Biomaterial BV
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Mermaid Medicals
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. ABK Biomedical
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Guerbet
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Endo Shape
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Instylla
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Shape Memory Medical
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Monteris Medical
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21. Trisalus Lifesciences
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients